Insider Transactions in Q2 2025 at Intra Cellular Therapies, Inc. (ITCI)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2025
|
Eduardo Rene Salas |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,567
-100.0%
|
$206,844
$132.0 P/Share
|
|
Apr 02
2025
|
Michael Halstead President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,307
-100.0%
|
$2,812,524
$132.0 P/Share
|
|
Apr 02
2025
|
Rory B Riggs |
SELL
Sale (or disposition) back to the issuer
|
Direct |
131,512
-100.0%
|
$17,359,584
$132.0 P/Share
|
|
Apr 02
2025
|
Mark Neumann EVP, Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,811
-100.0%
|
$6,971,052
$132.0 P/Share
|
|
Apr 02
2025
|
Robert L Van Nostrand |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,340
-100.0%
|
$1,496,880
$132.0 P/Share
|
|
Apr 02
2025
|
Suresh K. Durgam EVP, Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,913
-100.0%
|
$5,664,516
$132.0 P/Share
|
|
Apr 02
2025
|
Sharon Mates Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
190,000
-100.0%
|
$25,080,000
$132.0 P/Share
|
|
Apr 02
2025
|
Sharon Mates Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
945,235
-100.0%
|
$124,771,020
$132.0 P/Share
|
|
Apr 02
2025
|
Joel S Marcus |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,000
-100.0%
|
$1,320,000
$132.0 P/Share
|
|
Apr 02
2025
|
Joel S Marcus |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,238
-100.0%
|
$6,367,416
$132.0 P/Share
|